Reinnervate, Roslin Cellab partner to develop 3D stem cell printing products and services

Download PDF Copy

Reviewed

Sep 19 2013

Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services using Alvetex^® technology.

The two companies will pool their expertise in the areas of 3D cell culture and stem cell biology to bring next generation stem cell products and services to the market. Reinnervate will contribute new Alvetex 3D cell culture variants and expertise while Roslin Cellab will harness its capabilities in the area of stem cell culture and cell printing.

"We are delighted to deepen our links with Reinnervate by working together in this area" commented Dr. Jason King, Business Development Manager at Roslin Cellab. "This work builds on our earlier collaboration on the 3D culture and differentiation of stem cells using Alvetex" he added.

Richard Rowling, Commercial Director of Reinnervate Ltd said, "We are very pleased that Roslin Cellab has once again picked Alvetex technology as one of the most appropriate and flexible solutions for 3D cell culture for this new venture. The simple workflow and flexibility of Alvetex products make them an excellent companion for 3D cell printing projects".

Source:

http://reinnervate.com/

Posted in: Device / Technology News | Medical Science News

Comments (0)

Download PDF Copy

Suggested Reading

SwRI and UT San Antonio advance biosensor coating to streamline production of immunotherapies

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

New imaging technique enhances live-cell visualization in standard lab setups

Abnormal protein activity found to promote cell migration and spread of glioblastoma

Citrus flavonoid hesperidin lowers oxidative damage in cell experiments

Blocking immune brake protein boosts defense against Aspergillus fumigatus

Breakthrough in building functional synthetic kidneys using assembloids

Ifinatamab deruxtecan may benefit patients with recurrent or progressive ES-SCLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.